Cargando…
Evaluating the potential of novel genetic approaches for the treatment of Duchenne muscular dystrophy
Duchenne muscular dystrophy (DMD) is an X-linked progressive muscle-wasting disorder that is caused by a lack of functional dystrophin, a cytoplasmic protein necessary for the structural integrity of muscle. As variants in the dystrophin gene lead to a disruption of the reading frame, pharmacologica...
Autores principales: | Himič, Vratko, Davies, Kay E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440545/ https://www.ncbi.nlm.nih.gov/pubmed/33564172 http://dx.doi.org/10.1038/s41431-021-00811-2 |
Ejemplares similares
-
Regenerative biomarkers for Duchenne muscular dystrophy
por: Guiraud, Simon, et al.
Publicado: (2019) -
Advances in genetic therapeutic strategies for Duchenne muscular dystrophy
por: Guiraud, Simon, et al.
Publicado: (2015) -
Challenges to oligonucleotides-based therapeutics for Duchenne muscular dystrophy
por: Goyenvalle, Aurélie, et al.
Publicado: (2011) -
From diagnosis to therapy in Duchenne muscular dystrophy
por: Babbs, Arran, et al.
Publicado: (2020) -
Clinical potential of ataluren in the treatment of Duchenne muscular dystrophy
por: Namgoong, John Hyun, et al.
Publicado: (2016)